Key facts
- This page summarizes Vidya Ramnath's Form 4 filing for EMERSON ELECTRIC CO (EMR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Nov 2025, 16:21.
Vidya Ramnath - 06 Nov 2025 Form 4 Insider Report for EMERSON ELECTRIC CO (EMR)
- Reporting relationship
- Senior VP &CMO
- Issuer ticker
- EMR
- Reported as of
- 06 Nov 2025
- Net transaction value
- -$38,883
- SEC form
- 4
- Accepted by SEC
- 10 Nov 2025, 16:21:09 UTC
- Prior SEC filing
- 06 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John A. Sperino, Attorney-in-Fact for Vidya Ramnath
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Vidya Ramnath filed Form 4 for EMERSON ELECTRIC CO (EMR) on 10 Nov 2025.
Change
- Previous filing in this sequence was filed on 06 Nov 2025.
- Current net transaction value: -$38,883.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001973454
Primary reporting owner
Ramnath Vidya
- Relationship
- Senior VP &CMO
- Address
- C/O EMERSON ELECTRIC CO., 8027 FORSYTH BLVD., ST. LOUIS
- Signature
- /s/ John A. Sperino, Attorney-in-Fact for Vidya Ramnath
- Signature date
- 10 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EMR
transaction
Common Stock
Tax liability
- Transaction value
- $38,883
- Shares
- -293
- Change %
- -0.8%
- Price
- $132.70
- Shares after
- 36,284
- Date
- 06 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Shares withheld for required minimum taxes upon vesting of previously reported stock grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3.
Footnote F2
Fair market value on date of withholding described in Note 1.